Sanofi
Pharmaceutical compositions containing Clostridium difficile toxoids A and B

Abstract:

This invention relates to compositions including Clostridium difficile toxins and/or toxoids and corresponding methods. The compositions of the invention include one or more excipients that increase stability and/or decrease aggregation of the toxins.